1. Home
  2. VSEC vs TARS Comparison

VSEC vs TARS Comparison

Compare VSEC & TARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VSEC
  • TARS
  • Stock Information
  • Founded
  • VSEC 1959
  • TARS 2016
  • Country
  • VSEC United States
  • TARS United States
  • Employees
  • VSEC N/A
  • TARS N/A
  • Industry
  • VSEC Military/Government/Technical
  • TARS Medicinal Chemicals and Botanical Products
  • Sector
  • VSEC Consumer Discretionary
  • TARS Health Care
  • Exchange
  • VSEC Nasdaq
  • TARS Nasdaq
  • Market Cap
  • VSEC 3.4B
  • TARS 2.8B
  • IPO Year
  • VSEC N/A
  • TARS 2020
  • Fundamental
  • Price
  • VSEC $168.22
  • TARS $79.12
  • Analyst Decision
  • VSEC Strong Buy
  • TARS Strong Buy
  • Analyst Count
  • VSEC 5
  • TARS 8
  • Target Price
  • VSEC $196.80
  • TARS $73.63
  • AVG Volume (30 Days)
  • VSEC 331.3K
  • TARS 446.1K
  • Earning Date
  • VSEC 10-27-2025
  • TARS 11-04-2025
  • Dividend Yield
  • VSEC 0.24%
  • TARS N/A
  • EPS Growth
  • VSEC N/A
  • TARS N/A
  • EPS
  • VSEC 0.54
  • TARS N/A
  • Revenue
  • VSEC $1,332,372,000.00
  • TARS $366,100,000.00
  • Revenue This Year
  • VSEC $3.14
  • TARS $139.46
  • Revenue Next Year
  • VSEC $16.88
  • TARS $49.91
  • P/E Ratio
  • VSEC $308.99
  • TARS N/A
  • Revenue Growth
  • VSEC 67.77
  • TARS 182.44
  • 52 Week Low
  • VSEC $88.69
  • TARS $38.51
  • 52 Week High
  • VSEC $186.00
  • TARS $82.42
  • Technical
  • Relative Strength Index (RSI)
  • VSEC 46.62
  • TARS 69.16
  • Support Level
  • VSEC $162.95
  • TARS $70.84
  • Resistance Level
  • VSEC $174.50
  • TARS $82.42
  • Average True Range (ATR)
  • VSEC 7.01
  • TARS 3.73
  • MACD
  • VSEC -1.56
  • TARS 0.43
  • Stochastic Oscillator
  • VSEC 25.46
  • TARS 78.84

About VSEC VSE Corporation

VSE Corp is a diversified aftermarket products and services company providing repair services, parts distribution, logistics, supply chain management, and consulting services for land, sea, and air transportation assets to commercial and government markets. Its operations include supply chain management solutions, parts supply and distribution, and maintenance, repair, and overhaul (MRO) services for vehicle fleet, aviation, maritime and other customers. Its reportable segments are; Aviation and Fleet. The majority of the revenue for the company is generated from the Aviation segment which is a provider of aftermarket parts distribution and MRO services for components and engine accessories supporting commercial, business, and general aviation operators.

About TARS Tarsus Pharmaceuticals Inc.

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.

Share on Social Networks: